Literature DB >> 2538107

The effects of tumor necrosis factor and their selective inhibition by ibuprofen.

D A Evans1, D O Jacobs, A Revhaug, D W Wilmore.   

Abstract

High doses of tumor necrosis factor (TNF) cause hypotension, metabolic acidosis and, death. At Brigham and Women's Hospital, the effects of a sublethal, 6-hour infusion of TNF (0.57 X 10(5) Units/kg body weight) in twelve anesthetized dogs were studied. The dose caused falls in mean arterial pressure from 153 mmHg to 96 mmHg, pulmonary artery pressure (-4.5 mmHg), central venous pressure (-2.5 mmHg) and pulmonary capillary wedge pressures (-5.25 mmHg). Associated with these responses were a fourfold increase in urine volume (22.4 ml/kg/6 hours as compared to 5.2 ml/kg/6 hours in controls), significant pyrexia (from 38.1 C to 39.5 C, rectal), tachycardia (from 125 to 175 beats/minute), and hypermetabolism. In addition, leukopenia and increased circulating stress hormone concentrations were observed. Blood glucose concentrations fell from 4.68 mM/1 to 3.97 mM/1 (84-71 mg/dl) within 3 hours of TNF infusion, whereas lactate and pyruvate concentrations increased. These alterations occurred in the absence of severe hypotension or acidosis and were similar to changes observed after endotoxin administration or gram-negative septicemia. Pretreatment of the animals with the cyclooxygenase inhibitor ibuprofen abolished most of the hemodynamic changes and attenuated other responses. These findings support the hypothesis that TNF is an important mediator of septic responses and that some of the effects of TNF are mediated via cyclooxygenase pathways.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538107      PMCID: PMC1493947          DOI: 10.1097/00000658-198903000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

Review 1.  Metabolic response to infection.

Authors:  W R Beisel
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

Authors:  J D Peuler; G A Johnson
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

Review 3.  Prostaglandins and renal function.

Authors:  J C McGiff; K Crowshaw; H D Itskovitz
Journal:  Fed Proc       Date:  1974-01

4.  Glucagon radioimmunoassay using antiserum 30K: interference by plasma.

Authors:  G C Weir; R C Turner; D B Martin
Journal:  Horm Metab Res       Date:  1973-07       Impact factor: 2.936

5.  The effect of Escherichia coli endotoxin on the circulation.

Authors:  S K Brockman; C S Thomas; J S Vasko
Journal:  Surg Gynecol Obstet       Date:  1967-10

6.  Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.

Authors:  J S Soeldner; D Slone
Journal:  Diabetes       Date:  1965-12       Impact factor: 9.461

7.  Hemodynamic response to volume depletion in acutely uremic dogs.

Authors:  J T Daugirdas; T S Ing; W T Chen; R E Vestal; J L Izzo; J E Hano; M J Norusis
Journal:  Am J Physiol       Date:  1984-08

8.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

9.  Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog.

Authors:  J R Fletcher; P W Ramwell
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

10.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

View more
  15 in total

1.  Tumor necrosis factor-alpha is an endogenous inhibitor of Na+-K+-2Cl- cotransporter (NKCC2) isoform A in the thick ascending limb.

Authors:  Sailaja Battula; Shoujin Hao; Paulina L Pedraza; Charles T Stier; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Sepsis and tumor necrosis factor--bedfellows that cannot be ignored.

Authors:  H R Michie; D W Wilmore
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

3.  Renal-Specific Silencing of TNF (Tumor Necrosis Factor) Unmasks Salt-Dependent Increases in Blood Pressure via an NKCC2A (Na+-K+-2Cl- Cotransporter Isoform A)-Dependent Mechanism.

Authors:  Shoujin Hao; Mary Hao; Nicholas R Ferreri
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

4.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.

Authors:  F D Pagani; L S Baker; C Hsi; M Knox; M P Fink; M S Visner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 5.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

6.  Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis.

Authors:  H Holtmann; Y Shemer-Avni; K Wessel; I Sarov; D Wallach
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

7.  The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model.

Authors:  Ping Qiu; Yan Li; Yi Ding; Jia Weng; Steven M Banks; Steven Kern; Yvonne Fitz; Anthony F Suffredini; Peter Q Eichacker; Xizhong Cui
Journal:  Intensive Care Med       Date:  2011-08-30       Impact factor: 17.440

8.  The effects of tumor necrosis factor on intestinal structure and metabolism.

Authors:  J J van Lanschot; K Mealy; D W Wilmore
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

9.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  Therapy with antibody to tumor necrosis factor against endotoxin shock in rabbits.

Authors:  K Ishizaki; Y Youda; D M Yoon; K Arai; T Fujita
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.